Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma

Primary Study of the Function of a Novel Gene BC047440 Highly Expressed in Human Hepatocellular Carcinoma

Bc047440 Antisense Eukaryotic Expression Vectors Inhibited Hepg(2) Cell Proliferation and Suppressed Xenograft Tumorigenicity

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Identification and characterization of a novel human hepatocellular carcinoma-associated gene

Molecular Clone And Functional Study Of A Novel Hepatoma Associated Gene

Identification of CCDC115 As an Adverse Prognostic Biomarker in Liver Cancer Based on Bioinformatics and Experimental Analyses

KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma

Multiple Novel Hepatocellular Carcinoma Signature Genes Are Commonly Controlled by the Master Pluripotency Factor OCT4.

Cloning and Identification of a Novel Gene HCCA3 Highly Expressed in Human Hepatocellular Carcinoma and Its Clinicopathological Significance

Molecular cloning and characterization of LAPTM4B , a novel gene upregulated in hepatocellular carcinoma

The Human Homolog of Drosophila Headcase Acts As A Tumor Suppressor Through Its Blocking Effect on the Cell Cycle in Hepatocellular Carcinoma

[Cloning, prokaryotic expression and polyclonal antibody preparation of HCCR: a new biomarker for hepatocellular carcinoma].

HAX-1 is Overexpressed in Hepatocellular Carcinoma and Promotes Cell Proliferation.

HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein.

S100 Calcium Binding Protein A10, A Novel Oncogene, Promotes the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma.

Identification of hepatocellular carcinoma antigens by serological analysis of recombinant cDNA expression library and detection of hcct-19 expression in human tissues and cell lines

Expression and Function of CL-L1 in Hepatocellular Carcinoma

Cloning and Functional Characterization of A Novel Long Non-Coding Rna Gene Associated with Hepatocellular Carcinoma

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma

Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.